The Effect of Azithromycin on Relapse in Patients with Moderate-Severe Chronic Graft Versus Host Disease (CGVHD)

被引：0
|
作者：
Shamoun, Mark [1 ]
Braun, Thomas [2 ]
Magenau, John M. [3 ]
Choi, Sung Won [3 ]
Reddy, Pavan [3 ]
Pawarode, Attaphol [3 ]
Riwes, Mary M. [3 ]
Kitko, Carrie L. [4 ]
Anand, Sarah [3 ]
Ghosh, Monalisa [3 ]
Vander Lugt, Mark [3 ]
Bonifant, Challice [3 ]
Abusin, Ghada [3 ]
Parkin, Brian [3 ]
Peltier, Dan [3 ]
Yanik, Gregory A. [3 ]
机构：
[1] Univ Michigan, Pediat, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Publ Hlth, Biostat, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Blood & Marrow Transplantat Program, Ann Arbor, MI 48109 USA
[4] Vanderbilt Univ, Med Ctr, Pediat Blood & Marrow Transplantat Program, Nashville, TN USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
33
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Coping with moderate to severe chronic graft-versus-host disease (cGVHD) among hematopoietic stem cell transplant (HCT) survivors: A qualitative analysis.
    Fishman, Sarah
    El-Jawahri, Areej
    Traeger, Lara
    VanDusen, Harry
    Chen, Yi-Bin Albert
    Temel, Jennifer S.
    Driscoll, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26)
  • [32] Risk factors for moderate-to-severe chronic graft-versus-host disease in children
    Svennilson, J
    Remberger, M
    Gustafsson, B
    Gustafsson Jernberg, A
    Winiarski, J
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 2002, 29 : S208 - S208
  • [33] PLACENTAL INTRAVENOUS IMMUNOGLOBULIN (PtIVIG) FOR TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE (CGVHD)
    DPLu
    NLGuo
    HZheng
    XJHuang
    Chinese Medical Journal, 1994, (10)
  • [34] Extracorporal photopheresis (ECP) with Uvadex™ for the treatment of chronic graft versus host disease (cGVHD)
    Abhyankar, S
    Godder, K
    Chiang, KY
    Christiansen, N
    Brown, J
    DeRienzo, S
    O'Neal, W
    Henslee-Downey, PJ
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 781 - 781
  • [35] Treatment of refractory chronic graft versus host disease (cGVHD) with MMF: preliminary results
    Kalogiannidis, P
    Papadakis, E
    Sakellari, I
    Saloum, R
    Smias, C
    Lazidou, P
    Asimaki, A
    Tsakiri, A
    Anagnostopoulos, A
    Fassas, A
    BONE MARROW TRANSPLANTATION, 2002, 29 : S185 - S185
  • [36] Extracorporeal photochemotherapy (ECP) in patients with acute or chronic graft versus host disease (a/cGVHD): Clinical and immunological outcome
    Cristina, T
    Mario, A
    PierLuigi, T
    Arcangelo, P
    Valeria, G
    Anna, N
    Roberto, C
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 65 - 65
  • [37] Cataract surgery in patients with chronic severe graft-versus-host disease
    Shah, Ankit
    Santhiago, Marcony R.
    Espana, Edgar M.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2016, 42 (06): : 833 - 839
  • [38] Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
    Pidala, Joseph
    Kim, Jongphil
    Alsina, Melissa
    Ayala, Ernesto
    Betts, Brian C.
    Fernandez, Hugo F.
    Field, Teresa
    Jim, Heather
    Kharfan-Dabaja, Mohamed A.
    Locke, Frederick L.
    Mishra, Asmita
    Nishihori, Taiga
    Ochoa-Bayona, Leonel
    Perez, Lia
    Riches, Marcie
    Anasetti, Claudio
    HAEMATOLOGICA, 2015, 100 (07) : 970 - 977
  • [39] KETOTIFEN THERAPY IN CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) - EFFECT ON MAST-CELLS AND FIBROBLASTS
    NAGLER, A
    SEGAL, V
    SLAVIN, S
    LEVISCHAFFER, F
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 100 (03): : 529 - 535
  • [40] Absolute cytokine production by peripheral blood lymphocytes in patients with chronic cutaneous graft versus host disease (cGVHD)
    Salooja, N
    Tilling, R
    Russell-Jones, R
    Janossy, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S121 - S121
12345